0Suppliers
1Customers
3Debt Items
20Related Chains

Avalo Therapeutics, Inc. Suppliers

No suppliers on recordAvalo Therapeutics, Inc. has not yet been matched to upstream suppliers in our database, or is still being processed.

Avalo Therapeutics, Inc. Customers

TickerNameConfidenceEvidence
APOLLO APOLLO 90% In the event that J&J and/or Apollo are required to make payment(s) to ES Therapeutics pursuant to the underlying agreements, Avalo will recognize revenue under its existing contracts with those cust…

Avalo Therapeutics, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
AVTX-DEBT-8002 Xbrl Convertible 90% xbrl convertible detail from xbrl 2024-12-31.
AVTX-DEBT Debt stack $427,000 90% Market cache reports total debt of $427,000.
AVTX-DEBT-8001 Warrants outstanding: 4000000 90% xbrl warrant detail from xbrl 2025-12-31.

Avalo Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Avalo Therapeutics, Inc..

Avalo Therapeutics, Inc. Ownership

HolderNameConfidenceEvidence
AVTX-OWNER-FMR-LLC FMR LLC 90% 13F overlay lists FMR LLC as top holder; 101 tracked holders.

Avalo Therapeutics, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
ABBV AbbVie Inc. 100.00 2
ATON AlphaTON Capital Corp 100.00 2
TRIB Trinity Biotech plc 100.00 2
ADGM Adagio Medical Holdings, Inc. 100.00 2
ANIK Anika Therapeutics, Inc. 100.00 2
AURA Aura Biosciences, Inc. 100.00 2
CLGN CollPlant Biotechnologies Ltd. 100.00 2
BCAX Bicara Therapeutics Inc. 100.00 2
AVBP ArriVent BioPharma, Inc. 100.00 2
CYTOF Altamira Therapeutics Ltd. 100.00 2
BNR Burning Rock Biotech Limited 100.00 2
BNRG Brenmiller Energy Ltd 100.00 2
CSTE Caesarstone Ltd. 100.00 2
ACIU AC Immune SA 100.00 2
SNNUF Smith & Nephew plc 100.00 2
BLLN BillionToOne, Inc. 100.00 2
ALC Alcon Inc. 100.00 2
AORT Artivion, Inc. 100.00 2
ATRA Atara Biotherapeutics, Inc. 100.00 2
FDMT 4D Molecular Therapeutics, Inc. 100.00 2